Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study reveals how well seniors grasp their daily pills

NCT ID NCT07241299

Knowledge-focused Sponsor: Université de Reims Champagne-Ardenne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how well people over 65 understand the chronic medications they take regularly. Researchers will interview 150 patients to see if they know the dosage and purpose of each drug. The goal is to find gaps in understanding that could lead to better doctor-patient communication and improved treatment compliance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better communicate with older patients about their medications, potentially improving treatment adherence.
What could go wrong
This is an observational study with no treatment being tested, so it won't directly change health outcomes. Results may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged over 65, not living in a care home, with a prescription containing at least one medicine prescribed as part of their chronic treatment, defined as lasting more than 3 months, and agreeing to participate in the study.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are aged 65 or over * Consulting one of the general practitioners agreeing to participate in the study * Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months) * Agree to participate in the study. Exclusion Criteria: * Does not understand French, * Has neurocognitive disorders * Lives in a medical facility * Consulting for an acute condition and whose prescription does not include chronic treatment. * Protected by law (guardianship, curatorship, judicial protection),

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic treatments are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic treatments

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gestonnairedu CURRS

    RECRUITING

    Reims, Université de Reims Champagne-Ardenne, 51100, France

  • Ufr Medecine Urca

    RECRUITING

    Reims, 51100, France